Buchumschlag

Dapagliflozin Reduces Urinary Kidney Injury Biomarkers in Chronic Kidney Disease Irrespective of Albuminuria Level

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Junghyun Cho, Seung Whan Doo, Nayoung Song, Minsul Lee, Haekyung Lee, Hyongnae Kim, Jin Seok Jeon, Hyunjin Noh, Soon Hyo Kwon
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Clinical Pharmacology & Therapeutics
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Urinary Kidney Injury Biomarker Profiles in Healthy Individuals and After Nephrotoxic and Ischemic Injury
von: Sushrut S. Waikar, et al.
Veröffentlicht: (2025)

Cardiorenal Outcomes of Dapagliflozin vs. Empagliflozin in Advanced Chronic Kidney Disease and Diabetes
von: Shih‐Hsuan Lin, et al.
Veröffentlicht: (2026)

SGLT2 Inhibitors Increase Hemoglobin and Hematocrit Levels in Patients With Chronic Kidney Disease: A Systematic Review and Meta‐Analysis
von: Hye Duck Choi, et al.
Veröffentlicht: (2025)

Biomarkers of Drug‐Induced Kidney Injury: Use in Clinical Trials and Recent Examples of Impact on Drug Development
von: Tanja S. Zabka, et al.
Veröffentlicht: (2025)

Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Healthy Volunteers and Patients with Chronic Kidney Disease
von: Pamela Navarro‐Gonzales, et al.
Veröffentlicht: (2024)

Effect of Cardiac Rehabilitation on Cardiovascular Events in Patients With Advanced Chronic Kidney Disease
von: Tomoaki Hama, et al.
Veröffentlicht: (2025)

Prescribing Inflammatory Bowel Disease Medications in Chronic Kidney Disease: A Practical Guide
von: Lynna Chen, et al.
Veröffentlicht: (2025)

Correction to: Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Healthy Volunteers and Patients with Chronic Kidney Disease
Veröffentlicht: (2024)

Risk of Acute Kidney Injury Associated With Nephrotoxic Burden in Hospitalized Patients: A Scoping Review
von: Wafa Alatawi, et al.
Veröffentlicht: (2025)

Impact of Medium Cut‐Off Dialysis Membranes on Outcomes in COVID ‐19 Patients With Acute Kidney Injury
von: Omer Faruk Akcay, et al.
Veröffentlicht: (2025)

Diffusive Versus Convective Continuous Renal Replacement Therapy for Acute Kidney Injury: A Systematic Review and Meta‐Analysis
von: Fatima Masud, et al.
Veröffentlicht: (2026)

A Systematic Review of the Costs of Drug‐Associated Acute Kidney Injury and Potential Cost Savings With Nephrotoxin Stewardship Prevention Strategies
von: Britney A. Stottlemyer, et al.
Veröffentlicht: (2024)

MELD 3.0 Improves Risk Stratification and Mortality Prediction in Hepatorenal Syndrome‐Acute Kidney Injury: A Multicentre Study
von: Jing Ma, et al.
Veröffentlicht: (2025)

The Role and Mechanisms of Aurora Kinases in Kidney Diseases
von: Meiying Chang, et al.
Veröffentlicht: (2025)

Predicting OCT2 / MATEs ‐Mediated Drug Interactions in Healthy Volunteers and Patients with Chronic Kidney Disease: Insights from Extended Clearance Concept, Endogenous Biomarkers, and In Vitro Inhibition Studies (Perspectives from the International Transporter Consortium)
von: Satoshi Asano, et al.
Veröffentlicht: (2025)

Mortality of Acute Kidney Injury in Cirrhosis: A Systematic Review and Meta‐Analysis of Over 5 Million Patients Across Different Clinical Settings
von: Vasileios Lekakis, et al.
Veröffentlicht: (2024)

Cytochalasin B‐Induced Membrane Vesicles of NK Cells for Efficient Tumor Immunotherapy
von: Minseon Lee, et al.
Veröffentlicht: (2024)

Effect of Dapagliflozin on Measured vs. Panel‐Estimated Glomerular Filtration Rate
von: Esben Iversen, et al.
Veröffentlicht: (2024)

Mechanistic Determinants of Daprodustat Drug–Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of OATP1B‐CYP2C8 Interplay
von: Yi‐An Bi, et al.
Veröffentlicht: (2024)

Cardiovascular‐Kidney‐Metabolic Syndrome in People With HIV : An Emerging Frontier for Clinical Pharmacology
von: Aaron S. Devanathan, et al.
Veröffentlicht: (2025)

Stroke‐Induced Renal Dysfunction: Underlying Mechanisms and Challenges of the Brain–Kidney Axis
von: Xi Chen, et al.
Veröffentlicht: (2024)

Bradycardia and Other Arrhythmias in Patients With Hepatorenal Syndrome‐Acute Kidney Injury Following Terlipressin Treatment: A Pooled Analysis of Three North American Phase III Clinical Studies
von: Jasmohan S. Bajaj, et al.
Veröffentlicht: (2025)

Late Diagnosis of Chronic Hepatitis B in the United States: A Population‐Based, Retrospective Cohort Study From 2007 to 2021
von: Michael H. Le, et al.
Veröffentlicht: (2025)

Prediction of the Intra‐T Lymphocyte Tacrolimus Concentration after Kidney Transplantation with Population Pharmacokinetic Modeling
von: Suwasin Udomkarnjananun, et al.
Veröffentlicht: (2024)

Sex and the Kidney Drug‐Metabolizing Enzymes and Transporters: Are Preclinical Drug Disposition Data Translatable to Humans?
von: Aarzoo Thakur, et al.
Veröffentlicht: (2024)

Frequency of Home Therapy Among Patients Who Underwent Kidney Transplantation Followed by Maintenance Dialysis
von: Akihito Tanaka, et al.
Veröffentlicht: (2025)

P2Y12 Inhibitor or Aspirin Monotherapy for Chronic Coronary Disease: A Nationwide Cohort Study
von: Minyoul Baik, et al.
Veröffentlicht: (2025)

Continuous Kidney Replacement Therapy and Outcomes of Severe Coronavirus Disease 2019 Treated With Extracorporeal Membrane Oxygenation
von: Yoshito Izutani, et al.
Veröffentlicht: (2025)

Robust Predictive Performance of the SALT‐M Score for Clinical Outcomes in Asian Patients With Acute‐on‐Chronic Liver Failure
von: Kunhee Kim, et al.
Veröffentlicht: (2024)

Letter: Zinc and Selenium—Potential Biomarkers for Chronic Liver Disease? Authors' Reply
von: Nina Dominik, et al.
Veröffentlicht: (2024)

Alemtuzumab Exposure and T Lymphocyte Depletion: A Population Pharmacokinetic‐Pharmacodynamic Model of Alemtuzumab Induction Therapy for Kidney Transplantation
von: Lukas K. van Vugt, et al.
Veröffentlicht: (2025)

Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver Disease
von: Benedikt Simbrunner, et al.
Veröffentlicht: (2025)

Changes in Protein Expression of Renal Drug Transporters and Drug‐Metabolizing Enzymes in Autosomal Dominant Polycystic Kidney Disease Patients
von: Annika C. Tillmann, et al.
Veröffentlicht: (2025)

Better Rejection‐Free Survival at Three Years in Kidney Transplant Recipients With Model‐Informed Precision Dosing of Mycophenolate Mofetil
von: Claire Villeneuve, et al.
Veröffentlicht: (2024)

Chronic Intermittent Hypoxia‐Induced Neural Injury: Pathophysiology, Neurodegenerative Implications, and Therapeutic Insights
von: Nan‐Nan Jia, et al.
Veröffentlicht: (2025)

An Acellular Platform to Drive Urinary Bladder Tissue Regeneration
von: Mitali Kini, et al.
Veröffentlicht: (2024)

Timing of Kidney Replacement Therapy Initiation in Patients With Septic Shock: A Descriptive Study Using a Japanese Inpatient Database
von: Ken‐ichi Kano, et al.
Veröffentlicht: (2026)

Extent and Incidence of Pseudo‐Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real‐World Data
von: Michael I. Sponfeldner, et al.
Veröffentlicht: (2025)

Pseudo‐Worsening of Kidney Function Due to Inhibition of Renal Creatinine Secretion: Quality of Information Provided in Prescribing Information/SmPC
von: Michael I. Sponfeldner, et al.
Veröffentlicht: (2024)

Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease‐Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute‐on‐Chronic Liver Failure and Death
von: Mathias Jachs, et al.
Veröffentlicht: (2025)